The proposed training at the University of Pennsylvania will offer postdoctoral fellows (M.D.; M.D., Ph.D.; Ph.D.; D.V.M.; or D.V.M., Ph.D.) laboratory and didactic concentration on molecular, cellular, and whole animal aspects of cell growth and transformation that are relevant to the understanding of the origins and treatment of cancer. ? ? The program will concentrate our training efforts to deal with D.V.M.'s and M.D.'s or Ph.D.'s who wish to train in a Pathology based program that involves senior mentors from the School of Medicine and the School of Veterinary Medicine. The program offers focused and regular exposure to senior scientists at Penn. A novel program dedicated to histopathology of transgenic and knockout mice which have predisposition to developing tumors will be offered by members of the Pathology Departments. We are also developing another timely course, """"""""From Gene to Cell: An integrated approach to genomics, proteomics and cytomics."""""""" The course will include lectures and hands-on experience. This is a unique program that links didactic teaching to the most current studies of the origins of transformation. ? ? Drs. Mark Greene, M.D., Ph.D., Peter Felsburg, V.M.D., Ph.D., Peter Nowell, M.D., and Phillip Scott, Ph.D., will act as senior mentors in the training program. By formally including senior mentors from both schools we believe that we can provide unique guidance and perspectives to the fellows. ? ? Attention will be paid to ethical issues of science, and there will be a focused effort to increase the minority representation in the program. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA101968-02
Application #
6768856
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2004-07-30
Budget End
2005-06-30
Support Year
2
Fiscal Year
2004
Total Cost
$360,343
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Wood, Laurence M; Guirnalda, Patrick D; Seavey, Matthew M et al. (2008) Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors. Immunol Res 42:233-45
Basu, Samik; Golovina, Tatiana; Mikheeva, Tatiana et al. (2008) Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 180:5794-8
Paulos, Chrystal M; Suhoski, Megan M; Plesa, Gabriela et al. (2008) Adoptive immunotherapy: good habits instilled at youth have long-term benefits. Immunol Res 42:182-96
Barnhart, Bryan C; Lam, Jennifer C; Young, Regina M et al. (2008) Effects of 4E-BP1 expression on hypoxic cell cycle inhibition and tumor cell proliferation and survival. Cancer Biol Ther 7:1441-9
Tavaluc, Raluca T; Hart, Lori S; Dicker, David T et al. (2007) Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines. Cell Cycle 6:2554-62
Sussman, Robyn T; Ricci, M Stacey; Hart, Lori S et al. (2007) Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4. Cancer Biol Ther 6:1490-5
Yin, Hang; Slusky, Joanna S; Berger, Bryan W et al. (2007) Computational design of peptides that target transmembrane helices. Science 315:1817-22
Yin, Hang; Litvinov, Rustem I; Vilaire, Gaston et al. (2006) Activation of platelet alphaIIbbeta3 by an exogenous peptide corresponding to the transmembrane domain of alphaIIb. J Biol Chem 281:36732-41
Miller, Juli P; Stadanlick, Jason E; Cancro, Michael P (2006) Space, selection, and surveillance: setting boundaries with BLyS. J Immunol 176:6405-10
Tatko, Chad D; Nanda, Vikas; Lear, James D et al. (2006) Polar networks control oligomeric assembly in membranes. J Am Chem Soc 128:4170-1

Showing the most recent 10 out of 11 publications